EncounterCare Solutions, Inc.
ECSL · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | 3.13 | 1.30 | 0.73 |
| FCF Yield | -0.20% | -0.21% | -0.39% | -0.28% |
| EV / EBITDA | -305.65 | -546.96 | -255.22 | -153.70 |
| Quality | ||||
| ROIC | -1.12% | -0.44% | -25.11% | -42.21% |
| Gross Margin | 18.60% | -49.74% | -3.48% | -121.68% |
| Cash Conversion Ratio | 0.16 | 0.70 | 0.87 | 0.38 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.45% | 2.48% | 16.63% | 25.54% |
| Free Cash Flow Growth | -28.95% | 41.38% | -33.47% | 76.93% |
| Safety | ||||
| Net Debt / EBITDA | -81.36 | -164.22 | -6.90 | -3.90 |
| Interest Coverage | -0.68 | -5.56 | -7.96 | -11.92 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,304.47 | -1,537.66 | -23.44 | -27.91 |